КЛОУЗ Дэвид (GB),ГОДВУД Алекс (GB),ХОПТОН Марк (GB)
申请号：
RU2016149316
公开号：
RU2016149316A
申请日:
2015.05.18
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
Treatment of rheumatoid arthritis (RA) to provide clinical benefit in patients, including decrease in DAS28-CRP by more than 1.2 and/or improvement determined by ACR20, ACR50 or ACR70, comprising administering therapeutic antibody mavrilimumab.
